Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
Eugênio D. Hottz(Universidade Federal de Juiz de Fora), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Ester A. Barreto, Isaclaudia G. Azevedo-Quintanilha(Fundação Oswaldo Cruz), Cássia Righy(Instituto Estadual do Cérebro Paulo Niemeyer), Lohanna Palhinha(Fundação Oswaldo Cruz), Lívia Teixeira(Fundação Oswaldo Cruz), Fernando A. Bozza(D’Or Institute for Research and Education), Camila R. R. Pão(Fundação Oswaldo Cruz), Thiago Moreno L. Souza(National Institute of Science and Technology), Pedro Kurtz(D’Or Institute for Research and Education), Sérgio Franco(Instituto Estadual do Cérebro Paulo Niemeyer)
Cited by 776
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Lipid droplets: platforms with multiple functions in cancer hallmarks
|Cell Death and Disease|2020|530
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527
A Central Role for Free Heme in the Pathogenesis of Severe Sepsis
|Science Translational Medicine|2010|492